Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/17/24 19:00 | 5/15/24 | MRNA | Health | BioPrd | Biological Products, (No Diag | Afeyan Noubar | MA | D | 10 | S | -16,506 | 110.04 | 0 | -150 | 11,798 | D | ||||||||||||||||
5/17/24 16:04 | 5/15/24 | MRNA | Health | BioPrd | Biological Products, (No Diag | Hoge Stephen | MA | O | P | 6 | S.d | -5,321 | 110.97 | 0 | -48 | 1,672 | D | |||||||||||||||
4/9/24 16:09 | 4/8/24 | MRNA | Health | BioPrd | Biological Products, (No Diag | Mock James M | MA | O | CFO | 2 | S.d | -133 | 98.41 | 0 | -1 | 5 | D | |||||||||||||||
3/11/24 09:05 | 3/8/24 | MRNA | Health | BioPrd | Biological Products, (No Diag | Klinger Shannon Thyme | MA | O | GC | 3 | S.d | -128 | 96.38 | 0 | -1 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |